Advice

following a full submission 

camellia sinensis (green tea) leaf extract (Catephen®) is accepted for restricted use within NHS Scotland.

Indication under review: Cutaneous treatment of external genital and perianal warts (condylomata acuminata) in immunocompetent patients from the age of 18 years.

SMC restriction: for use in patients not suitable for podophyllotoxin or who have not responded to treatment with podophyllotoxin.

Complete clearance of baseline and new warts was achieved in a significantly higher proportion of patients treated for up to 16 weeks with camellia sinensis (green tea) 10% ointment than vehicle ointment, in two phase III randomised double-blind studies.

Download detailed advice232KB (PDF)

Download

Medicine details

Medicine name:
camellia sinensis (green tea leaf) (Catephen)
SMC ID:
1133/16
Indication:
for the cutaneous treatment of external genital and perianal warts (condylomata acuminata) in immunocompetent patients from the age of 18 years.
Pharmaceutical company
Kora Healthcare
BNF chapter
Skin
Submission type
Full
Status
Restricted
Date advice published:
10 April 2016